# Regeneron Pharmaceuticals, Inc.: Form 8-K, filed Feb 4, 2025

- Company: [Regeneron Pharmaceuticals, Inc.](/companies/regn.md) (CIK 872589)
- Form: 8-K
- Filed: 2025-02-04
- Accepted by EDGAR: Feb 4, 2025, 07:11 ET
- Period: 2025-02-04
- Accession: 0001804220-25-000007
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/872589/000180422025000007/regn-20250204.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/872589/000180422025000007/

## Items reported

- Item 2.02: Results of operations
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/872589/000180422025000007/regn-20250204.htm

Filed Feb 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001804220-25-000007. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.